Factors a Producer Considers Before Investing in R&D

Question

Producers in various market structures will employ certain strategies to increase their revenue and profits. One of such strategies is performing research and development. Producers can choose to invest in improving their existing products through product innovation, which will increase the demand for their products if done correctly.

Discuss the factors that producers would consider before deciding whether to invest in research and development. [15]

Answer

A producer is a rational, profit-maximising agent, and the rational decision-making framework sets out what it weighs before investing in R&D: the expected costs and benefits, and then the constraints, information and perspectives that condition them. I argue that, of these, the comparison of costs and benefits is the most important factor, because by the marginalist principle no constraint or perspective will induce a producer to invest unless the expected benefit exceeds the expected cost.

Costs and benefits. R&D yields a benefit in higher profit: by appealing more closely to consumers’ tastes and preferences, successful innovation raises demand for the firm’s product and so its revenue, and ceteris paribus its profit. Against this stand two costs. The explicit cost is large and monetary — R&D is time-consuming and expensive, requiring the firm to hire scientists and rent specialised equipment. The implicit cost is the opportunity cost: the budget devoted to R&D could have funded an alternative profit-raising strategy such as product diversification, and the profit that alternative would have yielded is forgone. By the marginalist principle, the producer invests only where the expected benefit exceeds the sum of explicit and implicit costs.

Constraints, information and perspectives. Three further factors condition the decision. First, information: with imperfect information on the expected costs, benefits and unintended consequences of R&D, the producer cannot reliably estimate its marginal efficiency of investment (MEI) and may postpone until it has gathered more. Second, budget constraints: because R&D carries a high fixed cost, a firm without sufficient funds to finance it is willing but unable to invest — a binding constraint particularly for small monopolistically competitive firms that earn no long-run supernormal profit. Third, perspectives. The producer weighs the likely reactions of three groups: the government, since an expected future R&D subsidy or grant may make it rational to postpone and invest more cheaply later; consumers, since R&D is worthwhile only if it genuinely shifts their tastes and preferences, so volatile or uncertain demand discourages it; and rival producers, since competitors able to free-ride on the innovation — where it cannot be protected by patents, copyrights or other legal barriers to entry — erode the firm’s expected return and may lead it to delay.

Evaluation and judgement. The cost–benefit comparison is the most important factor. The justification is the marginalist principle: however favourable the firm’s constraints, information or the perspectives of others, a producer will not invest in R&D unless the expected benefit outweighs the expected cost — so cost and benefit is the decisive consideration, with the other factors operating only as qualifications upon it. Two contextual points reinforce this. First, in an economy such as Singapore, with many large MNCs in oligopolistic industries earning supernormal profit, the budget constraint rarely binds, leaving the cost–benefit verdict to dominate. Second, although R&D raises monetary costs in the short run, its long-run benefits — higher product quality and demand — let the firm raise output and spread its fixed cost over more units, lowering average cost; so a short-run cost–benefit comparison may understate the case for investing, and a forward-looking producer weighs the long-run net benefit. The decision therefore turns, first and last, on whether expected benefit exceeds expected cost.